Regulation of Collagen Fibrillogenesis by Cell-surface Expression of Kinase Dead DDR2

Journal of Molecular Biology

Volumn 385, Issue 3, 2009, Pages 902-911

  Blissett, Angela R ^a,b   Garbellini, Derek ^a,b   Calomeni, Edward P ^b   Mihai, Cosmin ^a,b   Elton, Terry S ^a,b   Agarwal, Gunjan ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

collagen; DDR2; fibrillogenesis; TEM

Indexed keywords

COLLAGEN FIBRIL; HYDROXYPROLINE; KINASE DEAD DISCOIDIN DOMAIN RECEPTOR 2; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LINE; CELL SURFACE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; MICROMORPHOLOGY; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSMISSION ELECTRON MICROSCOPY;

EID: 58149105329     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.10.060     Document Type: Article

References (37)

1. Burgeson R.E., and Nimni M.E. Collagen types. Molecular structure and tissue distribution. Clin. Orthop. Relat. Res. 282 (1992)
2. Neame P.J., Kay C.J., McQuillan D.J., Beales M.P., and Hassell J.R. Independent modulation of collagen fibrillogenesis by decorin and lumican. Cell. Mol. Life Sci. 57 (2000) 859-863
3. Halász K., Kassner A., Mörgelin M., and Heinegård D. COMP acts as a catalyst in collagen fibrillogenesis. J. Biol. Chem. 282 (2007) 31166-31173
4. Kalamajski S., and Oldberg A. Fibromodulin binds collagen type I via Glu-353 and Lys-355 in leucine-rich repeat 11. J. Biol. Chem. 282 (2007) 26740-26745
5. Rentz T.J., Poobalarahi F., Bornstein P., Sage E.H., and Bradshaw A.D. SPARC regulates processing of procollagen I and collagen fibrillogenesis in dermal fibroblasts. J. Biol. Chem. 282 (2007) 22062-22071
6. Nicolae C., Ko Y.P., Miosge N., Niehoff A., Studer D., Enggist L., et al. Abnormal collagen fibrils in cartilage of matrilin-1/matrilin-3-deficient mice. J. Biol. Chem. 282 (2007) 22163-22175
7. Vogel W., Gish G.D., Alves F., and Pawson T. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol. Cell 1 (1997) 13-23
8. Shrivastava A., Radziejewski C., Campbell E., Kovac L., McGlynn M., Ryan T.E., et al. An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol. Cell 1 (1997) 25-34
9. Yamanaka R., Arao T., Yajima N., Tsuchiya N., Homma J., Tanaka R., et al. Identification of expressed genes characterizing long-term survival in malignant glioma patients. Oncogene 25 (2006) 5994-6002
10. Johansson F.K., Goransson H., and Westermark B. Expression analysis of genes involved in brain tumor progression driven by retroviral insertional mutagenesis in mice. Oncogene 24 (2005) 3896-3905
11. Ford C.E., Lau S.K., Zhu C.Q., Andersson T., Tsao M.S., and Vogel W.F. Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma. Br. J. Cancer 96 (2007) 808-814
12. Chua H.H., Yeh T.H., Wang Y.P., Huang Y.T., Sheen T.S., Lo Y.C., et al. Upregulation of discoidin domain receptor 2 in nasopharyngeal carcinoma. Head Neck 30 (2008) 427-436
13. Franco C., Hou G., and Bendeck M. Collagens, integrins, and the discoidin domain receptors in arterial occlusive disease. Trends Cardiovasc. Med. 12 (2002) 143-148
14. Ferri N., Carragher N.O., and Raines E.W. Role of Discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis. Am. J. Pathol. 164 (2004) 1575-1585
15. Li W., Zhang Y.Q., Liu X.P., Yao L.B., and Sun L. Regular expression of discoidin domain receptor 2 in the improved adjuvant-induced animal model for rheumatoid arthritis. Clin. Med. Sci. J. 20 (2005) 133-137
16. Xu L., Peng H., Wu D., Hu K., Goldring M.B., Olsen B.R., and Li Y. Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice. J. Biol. Chem. 280 (2005) 548-555
17. Vogel W. Discoidin domain receptors: structural relations and functional implications. FASEB J. 13 (1999) S77-S82
18. Mihai C., Iscru D.F., Druhan L.J., Elton T.S., and Agarwal G. Discoidin domain receptor 2 inhibits fibrillogenesis of collagen type I. J. Mol. Biol. 361 (2006) 864-876
19. Agarwal G., Mihai C., and Iscru D.F. Interaction of discoidin domain receptor 1 with collagen type 1. J. Mol. Biol. 367 (2007) 443-455
20. Pornprasertsuk S., Duarte W.R., Mochida Y., and Yamauchi M. Overexpression of lysyl hydroxylase-2b leads to defective collagen fibrillogenesis and matrix mineralization. J. Bone Miner. Res. 20 (2005) 81-87
21. Alves F., Saupe S., Ledwon M., Schaub F., Hiddemann W., and Vogel W.F. Identification of two novel, kinase-deficient variants of discoidin domain receptor 1: differential expression in human colon cancer cell lines. FASEB J. 15 (2001) 1321-1323
22. Alves F., Vogel W., Mossie K., Millauer B., Hofler H., and Ullrich A. Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer. Oncogene 10 (1995) 609-618
23. Karn T., Holtrich U., Brauninger A., Bohme B., Wolf G., Rubsamen-Waigmann H., and Strebhardt K. Structure, expression and chromosomal mapping of TKT from man and mouse: a new subclass of receptor tyrosine kinases with a factor VIII-like domain. Oncogene 8 (1993) 3433-3440
24. Lai C., and Lemke G. Structure and expression of the Tyro 10 receptor tyrosine kinase. Oncogene 9 (1994) 877-883
25. Jokinen J., Dadu E., Nykvist P., Käpylä J., White D.J., Ivaska J., et al. Integrin-mediated cell adhesion to type I collagen fibrils. J. Biol. Chem. 279 (2004) 31956-31963
26. Agarwal G., Kovac L., Radziejewski C., and Samuelsson S. Binding of discoidin domain receptor 2 to collagen I: an atomic force microscopy investigation. Biochemistry 41 (2002) 11091-11098
27. Konitsiotis A.D., Raynal N., Bihan D., Hohenester E., Farndale R.W., and Leitinger B. Characterization of high affinity binding motifs for the discoidin domain recptor DDR2 in collagen. J. Biol. Chem. 283 (2008) 6861-6868
28. Di Lullo G.A., Sweeney S.M., Korkko J., Ala-Kokko L., and San Antonio J.D. Mapping the ligand-binding sites and disease-associated mutations on the most abundant protein in the human, type I collagen. J. Biol. Chem. 277 (2002) 4223-4231
29. Rada J.A., Cornuet P.K., and Hassell J.R. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. Exp. Eye Res. 56 (1993) 635-648
30. Rühland C., Schönherr E., Robenek H., Hansen U., Iozzo R.V., Bruckner P., and Seidler D.G. The glycosaminoglycan chain of decorin plays an important role in collagen fibril formation at the early stages of fibrillogenesis. FEBS J. 274 (2007) 4246-4255
31. Notbohm H., Nokelainen M., Myllyharju J., Fietzek P.P., Müller P.K., and Kivirikko K.I. Recombinant human type II collagens with low and high levels of hydroxylysine and its glycosylated forms show marked differences in fibrillgenesis in vitro. J. Biol. Chem. 274 (1999) 8988-8992
32. Reigle K.L., Di Lullo G., Turner K.R., Last J.A., Chervoneva I., Birk D.E., et al. Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan binding and weakens cell adhesion. J. Cell Biochem. 104 (2008) 1684-1698
33. Contard P., Lloydstone J., Perlish J.S., and Fleischmajer R. Collagen fibrillogenesis in a three-dimensional fibroblast cell culture system. Cell Tissue Res. 273 (1993) 571-575
34. Birk D.E., Fitch J.M., Babiarz J.M., Doane K.J., and Linesenmayer T.F. Collagen Fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter. J. Cell Sci. 95 (1990) 649-657
35. Labrador J.P., Azcoitia V., Tuckermann J., Lin C., Olaso E., Mañes S., et al. The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism. EMBO Rep. 2 (2001) 446-452
36. Morales M.O., Price R.L., and Goldsmith E.C. Expression of discoidin domain receptor 2 (DDR2) in the developing heart. Microsc. Microanal. 11 (2005) 260-267
37. Reddy G.K., and Enwemeka C.S. A simplified method for the analysis of hydroxyproline in biological tissues. Clin. Biochem. 29 (1996) 225-229